Does TOFACITINIB Cause Duodenal ulcer perforation? 3,606 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,606 reports of Duodenal ulcer perforation have been filed in association with TOFACITINIB (XELJANZ XR). This represents 2.3% of all adverse event reports for TOFACITINIB.
3,606
Reports of Duodenal ulcer perforation with TOFACITINIB
2.3%
of all TOFACITINIB reports
1,480
Deaths
1,834
Hospitalizations
How Dangerous Is Duodenal ulcer perforation From TOFACITINIB?
Of the 3,606 reports, 1,480 (41.0%) resulted in death, 1,834 (50.9%) required hospitalization, and 1,742 (48.3%) were considered life-threatening.
Is Duodenal ulcer perforation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 3,606 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Duodenal ulcer perforation?
METHOTREXATE (4,239)
LEFLUNOMIDE (4,200)
FOLIC ACID (4,152)
ABATACEPT (4,147)
TOCILIZUMAB (4,130)
DICLOFENAC (4,120)
CETIRIZINE (4,117)
DESOXIMETASONE (4,084)
RITUXIMAB (4,081)
PREDNISONE (4,060)
Which TOFACITINIB Alternatives Have Lower Duodenal ulcer perforation Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN